BRUTON'S TYROSINE KINASE (BTK) INHIBITOR BGB-3111 DEMONSTRATES HIGH VERY GOOD PARTIAL RESPONSE (VGPR) RATE IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA (WM)

Subjects

Subjects :

0301 basic medicine
Very Good Partial Response
Cancer Research
biology
business.industry
Waldenstrom macroglobulinemia
Hematology
General Medicine
medicine.disease
03 medical and health sciences
BTK Inhibitor BGB-3111
030104 developmental biology
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
biology.protein
Cancer research
Medicine
Bruton's tyrosine kinase
In patient
business

Details

ISSN :

02780232

Volume :

35

Database :

OpenAIRE

Journal :

Hematological Oncology

Accession number :

edsair.doi...........106fd67a2a20714ad31de56f41b02b82

Full Text :

https://doi.org/10.1002/hon.2437_58